Media stories about Clorox (NYSE:CLX) have been trending somewhat positive recently, Accern reports. Accern ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Clorox earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned headlines about the company an impact score of 46.692060700753 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Here are some of the news headlines that may have impacted Accern Sentiment’s rankings:
- Dawn C. Willoughby Sells 3,387 Shares of Clorox Co (CLX) Stock (americanbankingnews.com)
- Clorox Will Start Printing Exactly What’s in Your Disinfectants (bloomberg.com)
- Clorox (CLX) Presents at Barclays Global Consumer Staples Conference – Slideshow (seekingalpha.com)
- Clorox Adding Detailed Ingredients To Labels (finance.yahoo.com)
- Clorox Plans On-Label Disclosure Of Ingredients In Household Cleaning Products (nasdaq.com)
Several research analysts have weighed in on the company. UBS Group assumed coverage on Clorox in a research note on Wednesday, July 18th. They issued a “sell” rating and a $110.00 price target for the company. BMO Capital Markets restated a “buy” rating and issued a $153.00 price target on shares of Clorox in a research note on Friday, August 3rd. ValuEngine upgraded Clorox from a “sell” rating to a “hold” rating in a research note on Tuesday, June 26th. Bank of America upped their price target on Clorox from $130.00 to $140.00 and gave the stock a “neutral” rating in a research note on Monday, July 16th. Finally, Goldman Sachs Group downgraded Clorox from a “neutral” rating to a “sell” rating and dropped their price target for the stock from $127.00 to $112.00 in a research note on Tuesday, July 17th. They noted that the move was a valuation call. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the company. The company has an average rating of “Hold” and an average target price of $130.42.
Shares of CLX opened at $150.74 on Friday. The company has a market cap of $19.02 billion, a PE ratio of 24.08, a PEG ratio of 3.07 and a beta of 0.35. Clorox has a 1 year low of $113.57 and a 1 year high of $151.02. The company has a debt-to-equity ratio of 3.15, a quick ratio of 0.67 and a current ratio of 1.09.
Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 2nd. The company reported $1.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.58 by $0.08. The business had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.72 billion. Clorox had a return on equity of 103.18% and a net margin of 13.44%. The company’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the prior year, the firm earned $1.53 EPS. equities analysts forecast that Clorox will post 6.41 EPS for the current fiscal year.
Clorox announced that its Board of Directors has initiated a stock buyback program on Thursday, May 24th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the company to purchase up to 12.6% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s board of directors believes its shares are undervalued.
In related news, COO Dawn C. Willoughby sold 3,387 shares of the stock in a transaction on Wednesday, September 5th. The stock was sold at an average price of $148.01, for a total transaction of $501,309.87. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Jon M. Balousek sold 3,354 shares of the stock in a transaction on Wednesday, August 29th. The shares were sold at an average price of $144.73, for a total value of $485,424.42. The disclosure for this sale can be found here. Insiders have sold a total of 28,886 shares of company stock worth $4,140,028 over the last ninety days. Insiders own 1.00% of the company’s stock.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Recommended Story: Stock Symbols Definition, Examples, Lookup
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.